Product & Service News
Health Economics Outcomes evaluation of Stago D-dimer
Improved patient outcomes and experience, shorter length of stay and cost effectiveness drive the recognition of value in today’s rapidly-evolving and competitive healthcare environment.
Read more
Stago Launches Fully Automated STA®-ECA II Assay for Dabigatran (Pradaxa®) Measurement
November 3, 2015, Parsippany, NJ, USA – Diagnostica Stago, Inc. expands its offering for measurement of direct oral anticoagulants (DOACs) with the launch of its next generation ecarin-based chromogenic assay for dabigatran,...
Read more
Stago Offers the Only Commercially Available Monoclonal Antibodies Anti-Human GPVI
2014/09/25: Glycoprotein VI (GPVI), a major collagen receptor playing a crucial role in collagen-induced platelet activation and aggregation, is a ~62-kDA type 1 transmembrane receptor belonging to the immunoglobulin superfamily.
Read more
Educational Resources from Diagnostica Stago: The Hemostasis Experts
September 9, 2013, Parsippany, NJ, USA – Diagnostica Stago Inc., offers expertise through two free electronic resources to educate healthcare professionals on hemostasis and thrombosis. The Stago-EdVantage web site and...
Read more
Haemtech Biopharma Services validates first Thrombin Generation assay for commercial IVIG product release
December 2013 - Essex Junction, Vermont – Haemtech Biopharma Services (HBS) is pleased to announce the successful validation of a thrombin generation assay (TGA) for an IVIG drug. The assay was validated in 2012 to support the...
Read more